feed,title,long_url,short_url
Benzinga,Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity,https://benzinga.com/general/biotech/23/03/31342277/analyst-says-biogen-eisais-alzheimers-treatment-leqembi-coverage-enables-access-to-over-2-5b-mark,https://da.gd/aD9H
